Shuang T, Wu S, Zhao Y, Yang Y, et al. The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells. BMC Cancer 2024;24:1213.
PMID: 39350056